Article
A mini review of genome-predicted β-lactam susceptibility in Streptococcus pneumoniae: from PBP profiles to potential clinical interpretation
22 Jul 2026
Abstract excerpt
β-Lactams remain central to the treatment of pneumococcal infections, and whole-genome sequencing increasingly enables pneumococcal β-lactam susceptibility to be inferred from the combined transpeptidase-domain sequences of PBP1a, PBP2b, and PBP2x. PBP-profile lookup, statistical models, and integrated genomic pipelines can predict drug-specific minimum inhibitory concentrations with high overall agreement with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
